Ajax Therapeutics
Developing targeted therapies for hematologic cancers through innovative cytokine signaling pathways. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD518—777m (Dealroom.co estimates May 2024.)
New York City New York (HQ)
Authorizing premium user...